Sector
ChemicalsOpen
₹46.8Prev. Close
₹44.78Turnover(Lac.)
₹1.2Day's High
₹46.8Day's Low
₹4552 Week's High
₹5452 Week's Low
₹21.1Book Value
₹14.82Face Value
₹10Mkt Cap (₹ Cr.)
23P/E
29.85EPS
1.5Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.67 | 1.17 | 0.7 | -0.73 |
Net Worth | 6.67 | 6.17 | 5.7 | 4.27 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 0.36 | 6.99 | 3.39 | 1.26 |
yoy growth (%) | -94.77 | 105.85 | 168.84 | -51.65 |
Raw materials | -0.12 | -3.53 | -1.54 | -0.62 |
As % of sales | 34.4 | 50.52 | 45.37 | 49.55 |
Employee costs | -0.77 | -0.63 | -0.57 | -0.4 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 0.93 | 2.25 | 1 | 0.79 |
Depreciation | -0.09 | -0.05 | -0.05 | -0.05 |
Tax paid | -0.45 | -0.8 | 0.01 | 0.11 |
Working capital | 0.52 | 1.83 | 1.28 | -0.03 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -94.77 | 105.85 | 168.84 | -51.65 |
Op profit growth | -205.7 | -308.67 | 0.71 | -275.86 |
EBIT growth | -58.68 | 125.09 | 25.84 | -33.27 |
Net profit growth | -67.21 | 92.35 | -17.48 | -23.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Pidilite Industries Ltd PIDILITIND | 3,109.1 | 87.8 | 1,58,131.73 | 354.32 | 0.51 | 2,588.88 | 163.92 |
SRF Ltd SRF | 2,399.2 | 56.5 | 71,118.24 | 249.94 | 0.3 | 2,676.63 | 353.96 |
Linde India Ltd LINDEINDIA | 8,058.05 | 162.92 | 68,719.05 | 104.33 | 0.15 | 630.07 | 402.73 |
Deepak Nitrite Ltd DEEPAKNTR | 2,951.9 | 113.97 | 40,261.86 | 115.68 | 0.25 | 671.15 | 216.61 |
Gujarat Fluorochemicals Ltd FLUOROCHEM | 3,158.05 | 82.84 | 34,691.18 | 86.01 | 0.1 | 1,043.2 | 539.16 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
MSR Ayyangar
Non Executive Director
Anuradha Raghavan
Non Executive Director
Sarada Raghavan
Independent Director
Anantharama Sethmani Subramanian
Executive Director & CFO
Jayavel Balaiah Nadar
Non Executive Director
Rajalakshmi Srinivasa Raghavan
Company Sec. & Compli. Officer
Priyanka Omprakash Sharma
Independent Director
Milind S Desai
Addtnl Independent Director
Dinesh Kumar Deora
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Emmessar Biotech & Nutrition Ltd
Summary
Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential.On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.ECILs research team established that the specialty chemicals made by them had potential as Vital Micro Nutrients, used worldwide in research as tools of Biotechnology. The Companys management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturers and consumers minds.EBNLs R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the US
Read More
The Emmessar Biotech & Nutrition Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹46 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Emmessar Biotech & Nutrition Ltd is ₹23.00 Cr. as of 26 Jul ‘24
The PE and PB ratios of Emmessar Biotech & Nutrition Ltd is 29.85 and 3.02 as of 26 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Emmessar Biotech & Nutrition Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Emmessar Biotech & Nutrition Ltd is ₹21.1 and ₹54 as of 26 Jul ‘24
Emmessar Biotech & Nutrition Ltd's CAGR for 5 Years at 26.91%, 3 Years at -3.29%, 1 Year at 85.35%, 6 Month at 66.59%, 3 Month at 11.17% and 1 Month at 10.02%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.